Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte supplement used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Potassium supplementation in patients receiving diuretic therapy or those with significant potassium losses (e.g., vomiting, diarrhea). ## Adult Dosing * **Prevention of Hypokalemia:** Oral: 20 mEq (1.5 g) daily. * **Treatment of Hypokalemia:** * Oral: 40-100 mEq (3-7.5 g) daily in 2-4 divided doses. Maximum oral dose typically 100 mEq/day, though higher doses may be used under close medical supervision. * Intravenous: Varies significantly based on severity of hypokalemia and cardiac status. * Mild hypokalemia (serum K+ 3.0-3.4 mEq/L): 10-20 mEq infused over several hours. * Moderate hypokalemia (serum K+ 2.5-2.9 mEq/L): 20-40 mEq infused over several hours. * Severe hypokalemia (serum K+ < 2.5 mEq/L) or cardiac arrhythmias: May require higher doses (up to 10 mEq/hour, rarely exceeding 20 mEq/hour and total dose of 200 mEq/24 hours) administered via central venous access with continuous cardiac monitoring. **Maximum infusion rate is typically 10-20 mEq/hour to reduce risk of hyperkalemia and cardiac arrest.** ## Pediatric Dosing * Dosing is highly individualized based on age, weight, and serum potassium levels. Local institutional protocols should be consulted. * General guidelines for maintenance potassium: 1-3 mEq/kg/day orally, not to exceed adult maximums. * Intravenous pediatric dosing should be done cautiously, often initiated at lower rates and concentrations than in adults, with frequent monitoring. Typical concentrations for peripheral IV administration should not exceed 40 mEq/L. Central line administration can tolerate higher concentrations (up to 100 mEq/L). ## Dose Adjustments * **Renal Impairment:** Use with extreme caution and may require dose reduction. Monitor potassium levels closely. In severe renal impairment, supplementation may be contraindicated. * **Adrenal Insufficiency:** Increased sensitivity to potassium. ## Contraindications * Severe renal impairment. * Hyperkalemia (serum K+ > 5.0 mEq/L). * Conditions where potassium may accumulate (e.g., anuria, severe burns, crush injuries, Addison's disease). * Uncorrected hyperkalemic acidosis. * Certain heart conditions (e.g., heart block without pacemaker). ## Adverse Effects * **Most Serious:** Hyperkalemia (potentially life-threatening, with symptoms including muscle weakness, fatigue, paresthesias, arrhythmias, cardiac arrest). * **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal discomfort, GI bleeding (especially with sustained-release oral formulations). * **Cardiovascular:** Arrhythmias, hypotension (with rapid IV infusion). * **Other:** Phlebitis (with IV administration). ## Key Drug Interactions * **Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), NSAIDs:** Can increase serum potassium levels. * **Digoxin:** Hyperkalemia can decrease digoxin efficacy; hypokalemia can increase digoxin toxicity. * **Anticholinergics:** May impair GI absorption of oral potassium chloride. * **Sodium Polystyrene Sulfonate:** May reduce GI absorption of potassium. ## Monitoring * **Serum Potassium:** Frequently monitor, especially during IV therapy, with dose changes, or in patients with renal impairment. * **Renal Function:** Monitor BUN and serum creatinine. * **ECG:** Especially with IV administration, in patients with pre-existing cardiac conditions, or if hyperkalemia is suspected. * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Oral potassium chloride can be irritating to the GI tract. Administer with food or fluids to minimize irritation. * Sustained-release formulations may cause significant GI side effects. * Intravenous potassium chloride administration requires extreme caution due to the risk of rapid hyperkalemia and cardiac arrest. **Always dilute IV potassium and never administer as a direct IV push.** * Patients with conditions affecting GI motility (e.g., gastroparesis, ileus) may have altered absorption or increased risk of GI ulceration with oral potassium. * The maximum recommended concentration for peripheral IV infusion of potassium chloride is typically 40 mEq/L. Higher concentrations require central venous access and continuous cardiac monitoring. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional guidelines before administering any medication.